Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $773.37 million. The enterprise value is $524.47 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 272.79 million shares outstanding. The number of shares has increased by 37.81% in one year.
| Current Share Class | 272.79M |
| Shares Outstanding | 272.79M |
| Shares Change (YoY) | +37.81% |
| Shares Change (QoQ) | +10.65% |
| Owned by Insiders (%) | 10.71% |
| Owned by Institutions (%) | 69.51% |
| Float | 173.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 96.79 |
| Forward PS | 130.95 |
| PB Ratio | 3.11 |
| P/TBV Ratio | 3.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 64.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.48, with a Debt / Equity ratio of 0.24.
| Current Ratio | 12.48 |
| Quick Ratio | 12.34 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,087.39 |
Financial Efficiency
Return on equity (ROE) is -51.86% and return on invested capital (ROIC) is -23.43%.
| Return on Equity (ROE) | -51.86% |
| Return on Assets (ROA) | -20.88% |
| Return on Invested Capital (ROIC) | -23.43% |
| Return on Capital Employed (ROCE) | -28.95% |
| Revenue Per Employee | $110,932 |
| Profits Per Employee | -$1.27M |
| Employee Count | 73 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.79% in the last 52 weeks. The beta is 0.96, so TSHA's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +26.79% |
| 50-Day Moving Average | 2.68 |
| 200-Day Moving Average | 2.16 |
| Relative Strength Index (RSI) | 50.86 |
| Average Volume (20 Days) | 2,770,646 |
Short Selling Information
The latest short interest is 36.41 million, so 13.35% of the outstanding shares have been sold short.
| Short Interest | 36.41M |
| Short Previous Month | 38.21M |
| Short % of Shares Out | 13.35% |
| Short % of Float | 21.01% |
| Short Ratio (days to cover) | 13.05 |
Income Statement
In the last 12 months, TSHA had revenue of $8.10 million and -$92.72 million in losses. Loss per share was -$0.34.
| Revenue | 8.10M |
| Gross Profit | 8.10M |
| Operating Income | -89.17M |
| Pretax Income | -118.01M |
| Net Income | -92.72M |
| EBITDA | -88.01M |
| EBIT | -89.17M |
| Loss Per Share | -$0.34 |
Full Income StatementBalance Sheet
The company has $312.76 million in cash and $59.76 million in debt, giving a net cash position of $253.00 million or $0.93 per share.
| Cash & Cash Equivalents | 312.76M |
| Total Debt | 59.76M |
| Net Cash | 253.00M |
| Net Cash Per Share | $0.93 |
| Equity (Book Value) | 248.73M |
| Book Value Per Share | 0.91 |
| Working Capital | 290.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$82.13 million and capital expenditures -$413,000, giving a free cash flow of -$82.54 million.
| Operating Cash Flow | -82.13M |
| Capital Expenditures | -413,000 |
| Free Cash Flow | -82.54M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,101.09% |
| Pretax Margin | -1,144.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.81% |
| Shareholder Yield | -37.81% |
| Earnings Yield | -11.93% |
| FCF Yield | -10.62% |
Analyst Forecast
The average price target for TSHA is $8.71, which is 207.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.71 |
| Price Target Difference | 207.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 125.45% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of 0.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.43 |
| Piotroski F-Score | 2 |
